Citi (C) Tops Q3 Views Excluding MSSB Loss, Positive Spread Effect on CVA/DVA

Go back to Citi (C) Tops Q3 Views Excluding MSSB Loss, Positive Spread Effect on CVA/DVA

While Not Perfect, Citigroup's (C) Q3 Showed Strong Progress - Analyst

October 15, 2012 10:30 AM EDT

Nomura Securities' bank analyst Glenn Schorr issued some commentary on Citi (NYSE: C) following results this morning.

While there were several moving parts, there was mostly progress everywhere in the quarter as "growth in the core businesses, shrinkage in Holdings, expense control/positive... More

Citigroup, Inc. (C) Tops Q3 EPS by 8c

October 15, 2012 7:59 AM EDT

Citigroup, Inc. (NYSE: C) reported Q3 EPS of $1.06, $0.08 better than the analyst estimate of $0.98. Revenue for the quarter came in at $19.41 billion versus the consensus estimate of $18.65 billion.

For earnings history and earnings-related data on Citigroup, Inc. (C) click here.... More